GLP-1 weight-loss drugs show promise for sleep apnea
New research indicates GLP-1 weight-loss medications like Mounjaro and Zepbound may offer therapeutic benefits for the one billion people with sleep apnea.
25 trends tracked about this subject — the full history, oldest to newest below.
New research indicates GLP-1 weight-loss medications like Mounjaro and Zepbound may offer therapeutic benefits for the one billion people with sleep apnea.
A new experimental weight loss injection has outperformed Mounjaro in a recent study, signaling a potential shift in obesity treatment.
Recent studies indicate that GLP-1 weight loss medications may worsen or accelerate hair loss in men.
A growing cultural and medical debate is emerging over the use of GLP-1 medications, focusing on the tension between clinical benefits and social stigma.
Concerns grow over the 'microdosing' of GLP-1 weight-loss medications as reports emerge regarding their effectiveness at low doses and long-term maintenance.
Mounting evidence highlights potential health benefits linked to the Shingrix vaccine, according to recent media coverage.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Experts call for safer weight loss methods as public and medical attention intensifies around the use and effectiveness of GLP-1 medications.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Regulators receive hundreds of reports linking popular weight-loss drugs to deaths.
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Medical reports highlight emerging cosmetic and physical side effects linked to rapid weight loss from GLP-1 receptor agonist medications.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
Amy Schumer shares unfiltered bikini photos from a yacht trip, highlighting her weight loss progress after a year on Mounjaro.
Australian regulators and medical reports link GLP-1 weight-loss drugs like Ozempic to a rare and severe risk of permanent vision loss.
New research links GLP-1 weight-loss medications like Ozempic and Mounjaro to an increased risk of hair loss in patients.
Pharmacists are issuing heatwave-related usage warnings for a wide range of medications as temperatures rise in England and Wales.